New MRSA Bacteria Killer Registered by EPA

The EPA (Environmental Protection Agency) has recently registered a new product for preventing and eliminating methicillin-resistant Staphylococcus aureus (MRSA), which causes potentially deadly infections commonly known as "staph" infections. The MRSA "super bug" is typically contracted in hospitals, in other healthcare environments, and in health clubs and locker rooms.
MRSA is usually spread by direct physical contact with those already infected or through indirect contact by touching objects (towels, clothes, sports equipment, etc.) that infected skin has contaminated. Consequently, any heavily trafficked area can be a source of infection.
Selectrocide� is greater than 99% pure chlorine dioxide, an ideal biocide because of its ability to kill viruses, bacteria, fungi, and algae at low saturation levels (parts per million) in a manner that does not allow pathogens to build resistance to the compound.

Prior to Selectrocide�, healthcare and health club environments were limited to using substances like bleach and quaternary ammonium compounds that can leave residue and require higher concentrations than does chlorine dioxide to achieve the same antimicrobial efficacy.

Selectrocide's chlorine dioxide is produced in water and sprayed, mopped, or sponged onto surfaces that require disinfection. After application, the solution is left on target surfaces and does not require rinsing. Due to the comparatively low application concentrations required to kill pathogens, Selectrocide is compatible with most materials.